Whole transcriptome analysis of breast tumors during neoadjuvant chemotherapy: association with response to preoperative chemotherapy
Introduction. Treatment of breast cancer often includes systemic neoadjuvant chemotherapy. The frequency of complete morphological response varies significantly depending on the molecular subtype of tumor. However, even in triple negative breast cancer, which is considered the most sensitive, it doe...
Saved in:
| Main Authors: | M. K. Ibragimova, M. M. Tsyganov, N. V. Litviakov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2022-03-01
|
| Series: | Успехи молекулярной онкологии |
| Subjects: | |
| Online Access: | https://umo.abvpress.ru/jour/article/view/414 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BRCA1 mRNA expression levels as an predictor of response to neoadjuvant chemotherapy in breast cancer
by: M. M. Tsyganov, et al.
Published: (2018-05-01) -
Dynamic predictive power of TP53 signatures in breast cancer prognosis: Pre- and post-neoadjuvant chemotherapy insights
by: Keiju Sasaki, et al.
Published: (2025-06-01) -
Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01) -
Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01) -
mRNA expression of chemosensitivity genes as a predictor of response to neoadjuvant chemotherapy in non-small cell lung cancer
by: M. M. Tsyganov, et al.
Published: (2019-02-01)